Laughter Yoga Intervention for People With Major Depressive Disorder
Laughter Yoga for Improving Depression, Anxiety and Stress in People Diagnosed With Major Depressive Disorder: A Feasibility Study
1 other identifier
interventional
50
1 country
1
Brief Summary
The present study will adopt a non-blinded parallel-group randomized controlled trial design that involves a Laughter Yoga group (intervention) and a treatment-as-usual group (Control). It aims to determine the feasibility of using LY intervention on patients with Major depressive disorder (MDD), and also to evaluate the potential effect of the intervention on comorbid depression, anxiety and stress for these patients. It is hypothesized that, LY group, as compared to the TAU group, will have significantly lower symptoms of depression, anxiety and stress, but greater improvements in self-reported mental health/physical health-related quality of life immediately post intervention and at 3 months' follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable major-depressive-disorder
Started Jun 2017
Shorter than P25 for not_applicable major-depressive-disorder
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 18, 2017
CompletedFirst Posted
Study publicly available on registry
May 23, 2017
CompletedStudy Start
First participant enrolled
June 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2018
CompletedFebruary 22, 2019
August 1, 2018
1.2 years
May 18, 2017
February 21, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Depression, Anxiety and Stress Scale (DASS-21) scores from baseline
Participants' levels of depression, anxiety and stress will be measured by using the Chinese version of the Depression Anxiety Stress Scale (DASS-21).
At baseline, immediately post intervention, and at 3 months after the intervention has been completed
Secondary Outcomes (1)
Change in Short form 12 item Health Survey (SF12v2) scores from baseline
At baseline, immediately post intervention, and at 3 months after the intervention has been completed
Other Outcomes (1)
Client Satisfaction Questionnaire (CSQ-8)
Immediately post intervention
Study Arms (2)
Laughter Yoga (LY) Group
EXPERIMENTALThe LY session will be offered twice weekly, for 45 minutes each time. Each participant will be asked to attend a total of 8 groups (over 4 weeks).
Treatment-as-usual (TAU)
NO INTERVENTIONThe TAU will receive their usual routine community mental health care (including medications) and attend medical outpatient appointments as determined by their individual needs.
Interventions
A LY group will be composed of 8-12 participants. Each sessions will include 4 essential elements steps of laughter yoga, laughter meditation and grounding exercises. The 4 steps of laughter yoga are 1) warm up exercise, 2) deep breathing exercises, 3) childlike playfulness and 4) laughter exercises. The laughter meditation is a deeper experience of unconditional laughter in which laughter often comes in natural waves and it becomes infectious and set off a chain reaction to infect other people. The grounding exercises allow individuals to ground the energy of laughter and relax. The LY intervention will be facilitated by a certified lead LY trainer.
Eligibility Criteria
You may qualify if:
- Diagnosed with and being treated for a major depressive disorder (F32, F33: ICD-10-CM) as confirmed by a psychiatrist
- Not receiving any other yoga or humour based intervention (currently or within the last three months)
- Be able to commit to attend the LY groups
- Current use of antidepressant for depression and with no plans to change the medication during the next 3 months
- Able to speak Chinese/English
- Able to provide written informed consent and considered safe and competent to participate in the study (as suggested by the attending psychiatrist),
- With co-morbid residual symptoms of anxiety, stress or depression (determined by minimum baseline DASS scores of 10 (depression), or 8 (anxiety) and/or 15 (stress).
You may not qualify if:
- A history of bipolar disorder or schizophrenia
- Physical health problems which may present risks if engaging in LY (i.e. hernia, injuries, etc. determined by the attending psychiatrist)
- Having co-morbidity of another chronic physical and/or mental health problem such as learning disability, substance misuse disorders and organic brain diseases
- Receiving any talking therapies at recruitment or throughout the study period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Castle Peak Hospital
Hong Kong, Hong Kong
Related Publications (4)
Attkisson CC, Zwick R. The client satisfaction questionnaire. Psychometric properties and correlations with service utilization and psychotherapy outcome. Eval Program Plann. 1982;5(3):233-7. doi: 10.1016/0149-7189(82)90074-x.
PMID: 10259963BACKGROUNDAttkisson, C.C. (2012). The CSQ Scales Reprint Portfolio. Mill Valley, CA: Tamalpais Matrix Systems, LLC.
BACKGROUNDLam ET, Lam CL, Fong DY, Huang WW. Is the SF-12 version 2 Health Survey a valid and equivalent substitute for the SF-36 version 2 Health Survey for the Chinese? J Eval Clin Pract. 2013 Feb;19(1):200-8. doi: 10.1111/j.1365-2753.2011.01800.x. Epub 2011 Nov 29.
PMID: 22128754BACKGROUNDLovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995 Mar;33(3):335-43. doi: 10.1016/0005-7967(94)00075-u.
PMID: 7726811BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel Bressington, PhD
School of Nursing, The Hong Kong Polytechnic University
- PRINCIPAL INVESTIGATOR
Wai Tong Chien, PhD
School of Nursing, The Hong Kong Polytechnic University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 18, 2017
First Posted
May 23, 2017
Study Start
June 1, 2017
Primary Completion
August 1, 2018
Study Completion
August 1, 2018
Last Updated
February 22, 2019
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share